Diagnos Laboratorium Utama Tbk. vs Nippon Indosari Corpindo Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Nippon Indosari Corpindo Tbk. trades at Rp605 (market cap 3.77T, 183.8K 24h volume). The key difference: Nippon Indosari Corpindo Tbk. is far larger — about 12.1× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 183.8K). Which is the better fit depends on your goals.
| DGNS | ROTI | |
|---|---|---|
Market Cap | 310.75B | 3.77T |
Volume | 963.6K | 183.8K |
Lot | 9.64K | 1.84K |
Turnover | 217.67M | 111.59M |
Average Price | 225.89 | 607.13 |
Value | 217.67M | 111.59M |
Indicative Equilibrium Price | 226 | 605 |
Indicative Equilibrium Volume | 1K | 330 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Nippon Indosari Corpindo (the company) was established under its original name of PT Nippon Indosari Corporation base on notarial deed No.11 of Benny Kristianto, S.H, dated on Mar 8, 1995. The Companys articles of association has been amended several times, most recently by notarial deed No. 71 of Isbandi, S.H., dated Feb 24, 2010, concerning among others, the change in the Company’s name, and public offering.
Read more on ROTI →